These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 3189368)
1. Clinically significant valvular heart disease in systemic lupus erythematosus. Straaton KV; Chatham WW; Reveille JD; Koopman WJ; Smith SH Am J Med; 1988 Nov; 85(5):645-50. PubMed ID: 3189368 [TBL] [Abstract][Full Text] [Related]
2. [Heart valve involvement in systemic lupus erythematosus: an echocardiographic study]. Marcon C; Moro E; Sforza P; Piccoli G; Maresca MC; Adami A G Ital Cardiol; 1992 Nov; 22(11):1301-8. PubMed ID: 1297616 [TBL] [Abstract][Full Text] [Related]
3. Association of lupus anticoagulant with severe valvular heart disease in systemic lupus erythematosus. Ford PM; Ford SE; Lillicrap DP J Rheumatol; 1988 Apr; 15(4):597-600. PubMed ID: 3135393 [TBL] [Abstract][Full Text] [Related]
4. Prevalence of infective endocarditis in patients with systemic lupus erythematosus. Miller CS; Egan RM; Falace DA; Rayens MK; Moore CR J Am Dent Assoc; 1999 Mar; 130(3):387-92. PubMed ID: 10085662 [TBL] [Abstract][Full Text] [Related]
5. Transthoracic versus transesophageal echocardiography for detection of Libman-Sacks endocarditis: a randomized controlled study. Roldan CA; Qualls CR; Sopko KS; Sibbitt WL J Rheumatol; 2008 Feb; 35(2):224-9. PubMed ID: 18085739 [TBL] [Abstract][Full Text] [Related]
13. Mitral valve disease of systemic lupus erythematosus. A cause of severe congestive heart failure reversed by valve replacement. Paget SA; Bulkley BH; Grauer LE; Seningen R Am J Med; 1975 Jul; 59(1):134-9. PubMed ID: 1138546 [TBL] [Abstract][Full Text] [Related]
14. Double-valve Libman-Sacks endocarditis: an entity that demands special consideration. Georghiou GP; Shapira Y; Drozd T; Erez E; Raanani E; Vidne BA; Sahar G J Heart Valve Dis; 2003 Nov; 12(6):797-801. PubMed ID: 14658823 [TBL] [Abstract][Full Text] [Related]
15. Cardiac valvular abnormalities are frequent in systemic lupus erythematosus patients with manifest arterial disease. Jensen-Urstad K; Svenungsson E; de Faire U; Silveira A; Witztum JL; Hamsten A; FrostegÄrd J Lupus; 2002; 11(11):744-52. PubMed ID: 12475005 [TBL] [Abstract][Full Text] [Related]
17. The association between systemic lupus erythematosus and valvular heart disease: an extensive data analysis. Watad A; Tiosano S; Grysman N; Comaneshter D; Cohen AD; Shoenfeld Y; Amital H Eur J Clin Invest; 2017 May; 47(5):366-371. PubMed ID: 28295225 [TBL] [Abstract][Full Text] [Related]
18. Double valve disease in systemic lupus erythematosus. Case report and literature review. Rose AG; Spracklen FH Am J Cardiovasc Pathol; 1987 Jan; 1(1):141-4. PubMed ID: 3331948 [TBL] [Abstract][Full Text] [Related]
19. Association of antiphospholipid antibodies with valvulopathy in systemic lupus erythematosus: a systematic review. Mattos P; Santiago MB Clin Rheumatol; 2011 Feb; 30(2):165-71. PubMed ID: 21207090 [TBL] [Abstract][Full Text] [Related]
20. Patients with systemic lupus erythematosus and antiphospholipid syndrome undergoing cardiac valve surgery. Arif R; Farag M; Seppelt P; Beller CJ; Ruhparwar A; Karck M; Kallenbach K J Heart Valve Dis; 2015 Mar; 24(2):228-35. PubMed ID: 26204691 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]